Half way through August this week , we should be hearing that...

Half way through August this week , we should be hearing that the Commercial run of MPL or "Our new Brand Name" has been completed.

Healey have 70 sites in the United States so logistics and delivery will be crucial prior to First Patient dosed announcement.
Exciting times ahead , Recruitment should be swift and PAA's reputation and previous positive data should be encouraging to attract Trial Patients..

MND patients are in high demand for trials , PAA having such a high safety profile and FDA ODD Designation should also provide confidence and security to prospective MND Trial Patients ,, NZT